Medical Cannabinoid Safety
Medical Cannabinoid Generalized Safety, Conditions and Contraindications
Contraindications for medical cannabinoid use warranting further consultation and review:
- Chronic Heart Failure (CHF)* cases can be evaluated on an individual basis
- Valvular disease/heart murmur (grade 3/4 or higher)--especially if heart failure is eminent
- Liver failure
Potential drug interactions:
Recommendation to offset current prescription by 2 hours to avoid prolonged sedation, ataxia, incoordination. After assessing the pet's response, may consider reduction in medication administration interval.
Offsetting cannabis from the prescriptions below is not 100% necessary all the time, it should be case by case and if side effects occur.
Benzodiazepines (Alprazolam, Buspirone, Diazepam)
Immunotherapy (Ex. Melanoma vaccines, T-cell therapies, Bone marrow transplants)
Conditions for multiple modality treatment:
Presumptive sedation for veterinary visits
Postoperative pain management
Elbow and hip dysplasia
Intervertebral disk disease (IVDD)
Ruptured cruciate management
Birth developmental bone/joint deformities
Brain Tumors - Gliomas
Mast Cell Tumors
Irritable bowel syndrome (IBD)
Feline idiopathic cystitis
Concerns of toxicity:Significant lethargy, ataxia, multiple episodes of vomiting, lateral recumbency, significant urinary incontinence, tremors, bradycardia, obtunded/comatose, tachycardia, respiratory depression.
Decontamination, Supportive Care, Monitoring, and medications may be indicated if deemed medically appropriate. We recommend contacting your primary veterinarian or a member of our team to triage potential dysphoria.